{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:52:51Z","timestamp":1792090371349,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","award":["ANR-16-CONV-0005"],"award-info":[{"award-number":["ANR-16-CONV-0005"]}],"id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008312","name":"Fondation Pierre Deniker pour la Recherche et la Pr\u00e9vention en Sant\u00e9 Mentale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijantimicag.2020.106274","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T11:47:23Z","timestamp":1609328843000},"page":"106274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine"],"prefix":"10.1016","volume":"57","author":[{"given":"Marion","family":"Plaze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-3889","authenticated-orcid":false,"given":"David","family":"Attali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Prot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Vinckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurine","family":"Levillayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Chiaravalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Perin-Dureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Simon-Loriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2020.106274_bib0001","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.encep.2020.04.010","article-title":"Repositionnement de la chlorpromazine dans le traitement du COVID-19: \u00e9tude reCoVery","volume":"46","author":"Plaze","year":"2020","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0002","first-page":"209","article-title":"Influence of chlorpromazine on the replication of influenza virus in chick embryo cells","volume":"26","author":"Krizanov\u00e1","year":"1982","journal-title":"Acta Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0003","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1128\/JVI.00024-06","article-title":"Hepatitis C virus entry depends on clathrin-mediated endocytosis","volume":"80","author":"Blanchard","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0004","doi-asserted-by":"crossref","first-page":"e28923","DOI":"10.1371\/journal.pone.0028923","article-title":"Inhibitors of alphavirus entry and replication identified with a stable chikungunya replicon cell line and virus-based assays","volume":"6","author":"Pohjala","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0005","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/JVI.74.5.2288-2292.2000","article-title":"JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis","volume":"74","author":"Pho","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0006","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","article-title":"Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine","volume":"84","author":"Nawa","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0007","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-0-387-33012-9_54","article-title":"Avian infectious bronchitis virus enters cells via the endocytic pathway","volume":"581","author":"Chu","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0008","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1128\/JVI.00837-08","article-title":"Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15","volume":"82","author":"Pu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2018.03.009","article-title":"Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low pH","volume":"518","author":"Persaud","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006685","article-title":"Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies","volume":"12","author":"Carro","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0011","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis","volume":"16","author":"Daniel","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0012","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0013","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1038\/s41598-018-25677-1","article-title":"Clathrin-mediated endocytosis is a candidate entry sorting mechanism for Bombyx mori cypovirus","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0014","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1128\/JVI.00253-07","article-title":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted","volume":"81","author":"Inoue","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0016","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0017","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0018","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194868","article-title":"MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells","volume":"13","author":"Cong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0020","doi-asserted-by":"crossref","first-page":"e01218","DOI":"10.1128\/JVI.01218-20","article-title":"Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo","volume":"94","author":"Weston","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0021","series-title":"COVID-19 situation update worldwide, as of 1 June 2020","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0023","doi-asserted-by":"crossref","first-page":"e00819","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0024","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/0006-2952(68)90180-9","article-title":"Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death","volume":"17","author":"Forrest","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0025","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/0024-3205(83)90742-7","article-title":"Distribution of chlorpromazine and imipramine in adipose and other tissues of rats","volume":"33","author":"Bickel","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0026","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03189648","article-title":"Autoradiographic and biochemical studies of drug distribution in the liver. II. [35S]Chlorpromazine and [14C]imipramine","volume":"9","author":"Fujii","year":"1984","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0027","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.2042-7158.1995.tb06741.x","article-title":"Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds","volume":"47","author":"Sgaragli","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0028","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archpsyc.1981.01780270088012","article-title":"Chlorpromazine levels and the outcome of treatment in schizophrenic patients","volume":"38","author":"May","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bcp.12785","article-title":"Repurposing some older drugs that cross the blood\u2013brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma","volume":"81","author":"Rundle-Thiele","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0031","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(76)90061-3","article-title":"The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism","volume":"40","author":"Wiesel","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(79)90024-6","article-title":"Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies","volume":"1","author":"Comar","year":"1979","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0033","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0034","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17474086.2019.1585238","article-title":"Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy","volume":"12","author":"Acharya","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0036","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jnci\/djz017","article-title":"CAR T-cell associated neurotoxicity: mechanisms, clinicopathologic correlates, and future directions","volume":"111","author":"Hunter","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0037","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1007\/s00415-020-09866-5","article-title":"CNS penetration of potential anti-COVID-19 drugs","volume":"267","author":"Richardson","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0038","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0039","first-page":"112","article-title":"[Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)]","volume":"110","author":"Delay","year":"1952","journal-title":"Ann Med Psychol (Paris)"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0040","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0041","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpainsymman.2012.10.042","article-title":"Nausea and vomiting in advanced cancer \u2013 the Cleveland Clinic Protocol (TH310)","volume":"45","author":"Gupta","year":"2013","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.ijantimicag.2020.106274_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache J Head Face Pain"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920305021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920305021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:40:00Z","timestamp":1760377200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920305021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0924857920305021"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106274","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.05.079608","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106274"}}